NEW YORK (GenomeWeb) – Cancer Genetics (CGI) reported on Thursday that its third quarter revenues grew 19 percent year over year as the company narrowed its net loss.
For the three months ended Sept. 30, the Rutherford, NJ-based molecular diagnostics firm had revenues of $8.0 million compared to $6.8 million in the year-ago period. Analysts, on average, had expected revenues of $7.9 million.